- Home
- NBIX vs SEIC Comparison
NBIX vs SEIC Comparison
Compare NBIX & SEIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBIX
- SEIC
- Stock Information
- Founded
- NBIX 1992
- SEIC 1968
- Country
- NBIX United States
- SEIC United States
- Employees
- NBIX 1448
- SEIC N/A
- Industry
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- SEIC Investment Bankers/Brokers/Service
- Sector
- NBIX Health Care
- SEIC Finance
- Exchange
- NBIX Nasdaq
- SEIC Nasdaq
- Market Cap
- NBIX 11.8B
- SEIC 10.4B
- IPO Year
- NBIX 1996
- SEIC N/A
- Fundamental
- Price
- NBIX $117.44
- SEIC $80.23
- Analyst Decision
- NBIX Buy
- SEIC Hold
- Analyst Count
- NBIX 24
- SEIC 5
- Target Price
- NBIX $163.91
- SEIC $75.20
- AVG Volume (30 Days)
- NBIX 1.0M
- SEIC 791.1K
- Earning Date
- NBIX 10-30-2024
- SEIC 10-23-2024
- Dividend Yield
- NBIX N/A
- SEIC 1.15%
- EPS Growth
- NBIX 97.40
- SEIC 23.19
- EPS
- NBIX 3.73
- SEIC 4.15
- Revenue
- NBIX $2,242,800,000.00
- SEIC $2,052,819,000.00
- Revenue This Year
- NBIX $26.97
- SEIC $13.09
- Revenue Next Year
- NBIX $16.69
- SEIC $7.60
- P/E Ratio
- NBIX $31.50
- SEIC $19.33
- Revenue Growth
- NBIX 25.72
- SEIC 8.53
- 52 Week Low
- NBIX $108.14
- SEIC $57.43
- 52 Week High
- NBIX $157.98
- SEIC $81.97
- Technical
- Relative Strength Index (RSI)
- NBIX 42.69
- SEIC 67.99
- Support Level
- NBIX $119.08
- SEIC $74.42
- Resistance Level
- NBIX $129.67
- SEIC $81.97
- Average True Range (ATR)
- NBIX 3.34
- SEIC 1.27
- MACD
- NBIX -0.02
- SEIC 0.19
- Stochastic Oscillator
- NBIX 14.59
- SEIC 76.95
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc is a research-based pharmaceutical company advancing drug candidates in the central nervous system and endocrine-related categories. The company's three late stage clinical programs are elagolix which is hormone releasing antagonist for women's health, opicapone which is an inhibitor for parkinson's patients, and ingrezza for tourette syndrome.
About SEIC SEI Investments Company
SEI Investments provides investment processing, management, and operations services to financial institutions, asset managers, asset owners, and financial advisors in four material segments: private banks, investment advisors, institutional investors, and investment managers. SEI also has a minority interest in LSV Asset Management, a value equity asset manager with about $99 billion in assets under management. As of December 2023, SEI (including LSV) manages, administers, or advises about $1.4 trillion in assets.